Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04908956
Title Osimertinib and Locally Ablative Radiotherapy in Patients With Synchronous Oligo-metastatic EGFR Mutant NSCLC (STEREO) (STEREO)
Acronym STEREO
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors European Thoracic Oncology Platform
Indications
Therapies
Age Groups: adult | senior
Covered Countries SWE | POL | NLD | ITA | ESP | CHE

Facility Status City State Zip Country Details
IRCCS - Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) Meldola 47014 Italy Details
Instituto Europeo di Oncologia (IEO) Milano Italy Details
AULSS2 Marca Trevigiana Treviso Treviso Italy Details
National Cancer Center Goyang-si 10408 Korea, Republic of Details
Severance Hospital, Yonsei University Health System Sinchon-dong Korea, Republic of Details
The Netherlands Cancer Institute Amsterdam Amsterdam 1006 BE Netherlands Details
Leiden University Medical Center Leiden Netherlands Details
Medical University Gdansk Gdańsk Poland Details
National University Hospital Singapore Singapore Details
Hospital General de Alicante Alicante 03010 Spain Details
Vall d'Hebron University Hospital Barcelona 08035 Spain Details
Catalan Institute of Oncology, L'Hospitalet de Llobregat Barcelona Spain Details
Centro Integral Oncologíco Clara Campal (CIOCC) HM Hospitales Madrid 28050 Spain Details
Hospital Clínico de Valencia Valencia Spain Details
Sahlgrenska University Hospital Gothenburg Sweden Details
Karolinska Universitetssjukhuset Solna Stockholm 171 76 Sweden Details
Kantonsspital Aarau Aarau Switzerland Details
Universitätsspital Zürich USZ Zürich 8091 Switzerland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field